The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
The recall announced in January involves contaminated broccoli sold in 20 states. Here's everything you need to know ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...